Novartis Ag (NVSEF) Profit After Tax (2009 - 2025)

Novartis Ag has disclosed Profit After Tax across 15 years of filings, most recently posting $4.0 billion for Q2 2025.

• Profit After Tax for Q2 2025 came in at $4.0 billion, up 23.97% year-over-year; the trailing twelve-month figure through Jun 2025 was $17.8 billion (up 66.6% YoY), and the FY2025 annual result was $14.0 billion, up 16.99% from the prior year.
• Profit After Tax came in at $4.0 billion for Q2 2025 at Novartis Ag, down from $5.9 billion in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $5.9 billion in Q4 2024 to a low of $514.0 million in Q1 2021.
• The 5-year median for Profit After Tax is $2.6 billion (2021), against an average of $2.6 billion.
• Across the five-year window, Profit After Tax surged 164.95% in 2021 and plunged 41.45% in 2022, its largest moves.
• Novartis Ag's Profit After Tax stood at $5.0 billion in 2021, then decreased by 20.99% to $3.9 billion in 2022, then grew by 17.81% to $4.6 billion in 2023, then increased by 28.69% to $5.9 billion in 2024, then tumbled by 32.19% to $4.0 billion in 2025.
• The last three Profit After Tax figures came in at $4.0 billion (Q2 2025), $5.9 billion (Q4 2024), and $3.2 billion (Q2 2024), per Business Quant data.